Trial Profile
Effect of Lanabecestat on the Pharmacokinetics of Ethinyl Estradiol and Levonorgestrel in Healthy Female Subjects
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase I
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Lanabecestat (Primary) ; Ethinylestradiol/levonorgestrel
- Indications Alzheimer's disease
- Focus Pharmacokinetics
- Sponsors Eli Lilly and Company
- 26 Jun 2018 Planned End Date changed from 19 Oct 2018 to 1 Oct 2018.
- 26 Jun 2018 Planned primary completion date changed from 19 Oct 2018 to 1 Oct 2018.
- 26 Jun 2018 Planned initiation date changed from 14 Jun 2018 to 1 Jun 2018.